Recombinant Human AGR2 Protein，His

AGR2 (anterior gradient 2) is a member of the anterior gradient family of proteins and has garnered significant interest in recent years due to its role in various biological processes and disease states, particularly in cancer. Initially identified as a protein involved in embryonic development and organogenesis, AGR2 has been linked to the regulation of epithelial cell homeostasis and differentiation. Its overexpression has been observed in various malignancies, including breast and lung cancers, correlating with aggressive tumor characteristics and poor prognostic outcomes. Given its potential as a biomarker and therapeutic target, researchers are increasingly focusing on the structural and functional analysis of recombinant AGR2 protein. The ability to produce recombinant AGR2 allows for the elucidation of its biological functions, interaction partners, and mechanisms of action at a molecular level. Additionally, understanding its molecular structure can inform potential drug design strategies aimed at inhibiting its function in cancer progression. The investigation of AGR2's role in cellular stress responses, protein folding, and secretion further emphasizes its significance in pathophysiology. Overall, the research on recombinant AGR2 protein provides a foundation for novel diagnostic and therapeutic approaches in cancer treatment, highlighting the need for continued exploration of its biological implications and clinical relevance.